Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by MYSTICALon Dec 03, 2015 9:13am
175 Views
Post# 24349808

RE:A valuation update.

RE:A valuation update.FD<br /> <br /> Great analysis.<br /> <br /> Do you know if anything is going on with Nantworks?<br /> Or are the plasma derived biopharmaceuticals are already identified in your analysis.<br /> <br /> Its seems its been a long time since we heard about Dr. Patrick Soon-Shiong<br /> <h2> <a href="https://www.prometic.com/prometic-life-sciences-and-nantpharma-a-nantworks-company-to-develop-and-commercialize-plasma-derived-biopharmaceuticals/">PROMETIC LIFE SCIENCES AND NANTPHARMA, A NANTWORKS COMPANY, TO DEVELOP AND COMMERCIALIZE PLASMA-DERIVED BIOPHARMACEUTICALS</a></h2>
Bullboard Posts